SCHEMBL7120462

SCHEMBL7120462

Cc1ccc(-c2nc(NC(=O)c3cc([N+](=O)[O-])ccc3Cl)sc2C)cc1Cl

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TASP1 Q9H6P5 1/20 0.54
RORC P51449 4/20 0.53
MAPT P10636 6/20 0.53
SMN1; SMN2 Q16637 6/20 0.53
HTT P42858 4/20 0.53
S1PR4 O95977 2/20 0.53
S1PR1 P21453 2/20 0.53
KMT2A Q03164 4/20 0.52
MEN1 O00255 3/20 0.52
POLB P06746 2/20 0.52
GAA P10253 2/20 0.52
PPARG P37231 4/20 0.52
LMNA P02545 3/20 0.50
KDM4E B2RXH2 1/20 0.49
ALDH1A1 P00352 1/20 0.49
HPGD P15428 1/20 0.49
CYP3A4 P08684 2/20 0.49
MAPK1 P28482 2/20 0.49
ALOX15 P16050 1/20 0.49
PPARA Q07869 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27571318 0.88 RORC (0.47) RORCMAPTSMN1; SMN2HTTS1PR4
SCHEMBL7130981 0.84 MAPT (0.62) RORCMAPTSMN1; SMN2HTTKMT2A
SCHEMBL31665465 0.78 MAPT (0.56) RORCMAPTSMN1; SMN2HTTKMT2A
SCHEMBL7162058 0.75 DYRK1A (0.64) MAPTSMN1; SMN2HTTKMT2AMEN1
SCHEMBL7128930 0.75 RORC (0.59) RORCMAPTSMN1; SMN2HTTKMT2A
SCHEMBL7128392 0.75 SMN1; SMN2 (0.65) RORCMAPTSMN1; SMN2HTTKMT2A
SCHEMBL7129461 0.75 DYRK1A (0.70) MAPTSMN1; SMN2HTTKMT2AMEN1
SCHEMBL7127621 0.73 ABL1 (0.63) RORCMAPTSMN1; SMN2HTTKMT2A
SCHEMBL7129246 0.73 RORC (0.63) RORCMAPTSMN1; SMN2HTTKMT2A
SCHEMBL5731624 0.73 MAPT (0.69) RORCMAPTSMN1; SMN2HTTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030134859-A1 PPAR-gamma modulator SANKYO COMPANY, LIMITED (JP) 2003-07-17 US disclosed
EP-1277729-A1 PPAR (GAMMA) MODULATORS Sankyo Company, Limited (JP) 2003-01-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030134859-A1 PPAR-gamma modulator PPARG, PPARA, PPARD TASP1 4387/4885RORC 67/4885MAPT 4391/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.